Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical Trial Results Soon

LOS ANGELES, CA, Apr 19, 2012 (MARKETWIRE via COMTEX) -- In an exclusive Expert Briefing at BioMedReports, Yuichi Iwaki, M.D., Ph.D., the Founder, President and Chief Executive Officer of MediciNova, Inc. MNOV +6.46% tells investors about a promising treatment approach aimed at meeting the need for novel treatments for patients suffering from acute exacerbations of asthma (AEA), a long-lasting and severe form of asthma episode in which symptoms are unresponsive to initial bronchodilator or corticosteroid therapy...

Read more: marketwatch.com



Asthma drug 'protects sufferers from life-threatening symptoms caused by common cold'

Scientists are developing a drug that will protect asthma sufferers from life-threatening symptoms caused by the common cold...

Read more: dailymail.co.uk



Asthma in children: Signs & diagnosis

TRAVERSE CITY -- Dr. Karla Smith from the Traverse Area Pediatrics and Adolescent Clinic said physicians and parents are encouraging children to be physically active, but some children and adolescents may have problems "keeping up" when they exercise...

Read more: upnorthlive.com